Karyopharm Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	60.54	62.48	52.23	135.19	190.46
Short-Term Investments	3.2	46.24	139.21	142.78	38.16
Cash & Short-Term Investments	63.74	108.71	191.44	277.97	228.62
Cash Growth	-41.36%	-43.21%	-31.13%	21.59%	-8.28%
Receivables	26.18	30.77	27.96	54.89	23.9
Inventory	4.04	4.74	3.04	4.22	4.11
Prepaid Expenses	9.19	12.25	10.81	12.02	12.64
Restricted Cash	-	-	0.66	1.06	6.35
Total Current Assets	103.15	156.46	233.92	350.16	275.61
Property, Plant & Equipment	4.65	6.28	4.88	7.38	9.56
Long-Term Accounts Receivable	-	-	-	-	19.51
Other Long-Term Assets	0.62	1.67	1.64	0.63	0.64
Total Assets	108.42	164.42	240.44	358.17	305.31
Accounts Payable	4	5.11	3.12	2.77	1.6
Accrued Expenses	64.5	60.65	61.39	58.42	69.12
Short-Term Debt	-	24.43	-	-	-
Current Portion of Long-Term Debt	21.01	-	-	-	-
Current Portion of Leases	0.97	0.44	3.31	2.87	2.32
Other Current Liabilities	1.58	1.64	1.65	1.85	0.68
Total Current Liabilities	92.06	92.26	69.48	65.91	73.72
Long-Term Debt	278.22	236.45	303.4	302.82	302.29
Long-Term Leases	5.74	6.71	2.79	6.1	8.97
Other Long-Term Liabilities	25.32	15.01	0.98	-	-
Total Liabilities	401.34	350.44	376.64	374.83	384.98
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,466	1,378	1,351	1,328	1,099
Retained Earnings	-1,759	-1,563	-1,487	-1,344	-1,179
Comprehensive Income & Other	0.07	-0.36	-0.16	-0.64	0.19
Shareholders' Equity	-292.93	-186.02	-136.21	-16.66	-79.67
Total Liabilities & Equity	108.42	164.42	240.44	358.17	305.31
Total Debt	305.95	268.02	309.5	311.79	313.58
Net Cash (Debt)	-242.2	-159.31	-118.05	-33.83	-84.96
Net Cash Per Share	-22.15	-18.84	-15.50	-6.20	-16.94
Filing Date Shares Outstanding	18.34	8.42	7.67	7.56	5.28
Total Common Shares Outstanding	18.31	8.41	7.66	7.55	5.05
Working Capital	11.09	64.2	164.44	284.25	201.89
Book Value Per Share	-16.00	-22.11	-17.78	-2.21	-15.78
Tangible Book Value	-292.93	-186.02	-136.21	-16.66	-79.67
Tangible Book Value Per Share	-16.00	-22.11	-17.78	-2.21	-15.78
Machinery	2.21	2.21	2.29	2.33	2.25
Leasehold Improvements	3.4	4.88	4.88	5.45	5.45

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q